{"product_id":"hzkangji-five-forces-analysis","title":"Hangzhou Kangji Medical Equipment Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Preview—Access the Full Strategic Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cphangzhou kangji operates in a moderately concentrated medical-device market where supplier specialization and regulatory barriers raise switching costs while growing healthcare demand tempers buyer power competitive rivalry hinges on product differentiation after-sales service intensity.\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Hangzhou Kangji Medical Equipment’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/phangzhou\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandardization of Raw Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe primary inputs for surgical instruments—medical-grade stainless steel and specialty plastics—are commodity-like and supplied by many firms; global stainless steel production hit 1.86 billion tonnes in 2024, keeping supply plentiful.\u003c\/p\u003e\n\u003cp\u003eBecause materials are standardized, Hangzhou Kangji Medical Equipment can swap vendors with minimal retooling, lowering switching costs and production risk. \u003c\/p\u003e\n\u003cp\u003eThis vendor abundance keeps individual suppliers' bargaining power low, supporting stable input pricing and a gross-margin advantage. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Electronic Component Dependencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFor advanced products like integrated OR solutions and electronic medical pendants, Kangji depends on specialized sensors and microprocessors made by a small vendor pool, giving suppliers modest leverage; about 60–70% of such high-tech parts in China come from five firms as of 2025. Kangji’s revenue growth to RMB 1.2 billion in 2024–25 improved bargaining power, enabling multi-year contracts and price rebates of roughly 3–6% on key components.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Fragmentation in the Domestic Market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Chinese medical-device components market remains fragmented: over 6,000 SMEs supplied parts in 2024, keeping supplier concentration low and prices competitive.\u003c\/p\u003e\n\u003cp\u003eKangji (Hangzhou Kangji Medical Equipment Co., Ltd.) exploits this by multi-sourcing and running parallel RFQs, cutting input costs by about 4–7% vs. single-supplier deals in 2024.\u003c\/p\u003e\n\u003cp\u003eNo supplier holds decisive leverage, so Kangji secures net payment terms of 60–75 days, protecting its margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVertical Integration Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eKangji has moved key component production in-house, raising vertical integration to about 28% of components by value in 2024, cutting external vendor spend by roughly CNY 120m (≈USD 17m) versus 2022.\u003c\/p\u003e\n\u003cp\u003eControlling more supply reduced lead-time variability by 35% and limited input-price exposure during 2023–24, effectively neutralizing bargaining power of third-party suppliers for critical surgical tool parts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e28% components in-house (2024)\u003c\/li\u003e\n\u003cli\u003eCNY 120m vendor spend cut vs 2022\u003c\/li\u003e\n\u003cli\u003e35% lower lead-time variability\u003c\/li\u003e\n\u003cli\u003eReduced supplier price volatility exposure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwitching Costs and Quality Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSwitching suppliers for medical-grade components demands rigorous quality audits to meet NMPA (National Medical Products Administration) standards, creating a modest barrier: new vendors need certification and on-site inspections that typically take 60–120 days.\u003c\/p\u003e\n\u003cp\u003eDespite compliance steps, switching costs are small versus Kangji’s annual procurement (~RMB 480 million in 2024), since component unit costs are low and volume gives negotiating leverage.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory vetting: 60–120 days\u003c\/li\u003e\n\u003cli\u003eAnnual procurement: ~RMB 480 million (2024)\u003c\/li\u003e\n\u003cli\u003eBarrier: minor but non-negligible\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKangji Cuts Costs, Secures Terms—Supplier Power Remains Low Amid Supplier Concentration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers' power is generally low: commodity inputs are abundant (global stainless steel 1.86bn t in 2024) and Kangji multi-sources, with 28% of components in-house and ~RMB 480m procurement (2024), securing 60–75 day terms and 3–6% rebates on high-tech parts. Specialized sensors (60–70% from five firms) give modest leverage, but Kangji’s CNY 120m vendor spend cut and 35% lower lead-time variability limit supplier influence.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024–25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement\u003c\/td\u003e\n\u003ctd\u003e~RMB 480m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIn-house components\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVendor spend cut vs 2022\u003c\/td\u003e\n\u003ctd\u003eCNY 120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead-time variability\u003c\/td\u003e\n\u003ctd\u003e-35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePayment terms\u003c\/td\u003e\n\u003ctd\u003e60–75 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSteel supply\u003c\/td\u003e\n\u003ctd\u003e1.86bn t (global, 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh-tech part concentration\u003c\/td\u003e\n\u003ctd\u003e60–70% from 5 firms\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Hangzhou Kangji Medical Equipment, this Porter's Five Forces analysis uncovers competitive drivers, buyer and supplier power, entry barriers, substitutes, and disruptive threats shaping the company’s pricing, profitability, and strategic positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise Porter's Five Forces summary for Hangzhou Kangji Medical Equipment—quickly spot supplier, buyer, entrant, substitute, and competitive pressures to guide strategic moves and investor briefs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of Volume-Based Procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Chinese government’s Volume-Based Procurement (VBP) programs remain the dominant driver of customer bargaining power through 2025, forcing suppliers to accept steep cuts; the 2024 national VBP round recorded average price reductions of 56% for selected consumables, setting the benchmark for 2025 negotiations.\u003c\/p\u003e\n\u003cp\u003eBy aggregating demand across provinces, public hospitals secure guaranteed volumes—Kangji faces contract bids worth RMB 200–800 million per SKU in provincial pools—so suppliers trade margin for scale.\u003c\/p\u003e\n\u003cp\u003eThis centralized buying compressed sector margins: median gross margin for Chinese medical consumables fell from 34% in 2019 to ~18% in 2024, pressuring Kangji’s pricing power and R\u0026amp;D spend.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Public Hospital Groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge public hospital networks and provincial health bureaus are Kangji’s main buyers, buying surgical tables and OR systems in multi-unit contracts; in 2024 Zhejiang province hospitals ordered ~1,200 OR suites, giving buyers volume leverage.\u003c\/p\u003e\n\u003cp\u003eThese buyers force price concessions and demand bundled services; procurement tenders often require 5–10 year warranties and SLAs, shifting lifecycle costs to suppliers and raising customer bargaining power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow Switching Costs for Consumables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFor basic consumables like trocars and forceps, hospitals face low switching costs from Hangzhou Kangji Medical Equipment to other domestic brands, so price and availability drive procurement; industry surveys in 2024 show 68% of Chinese hospitals prioritize price for standardized disposables, and Kangji saw a 4.1% margin compression in FY2024 versus FY2023 as it cut prices to match rivals, forcing sustained competitive pricing to protect share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributor Influence in Tier 2 and 3 Cities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eKangji relies on distributors to reach smaller hospitals in lower-tier Chinese cities; about 60% of its non-urban sales pass through local dealers as of 2025.\u003c\/p\u003e\n\u003cp\u003eDistributors carry multiple brands and steer purchases toward higher-margin lines, forcing Kangji to offer 8–15% higher distributor margins and marketing support to stay preferred.\u003c\/p\u003e\n\u003cp\u003eFailure to match incentives risks share loss in regions where Kangji earns roughly 25% of its revenue, so distributor terms materially affect profitability.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~60% non-urban sales via distributors\u003c\/li\u003e\n\u003cli\u003eDistributor margin uplift 8–15%\u003c\/li\u003e\n\u003cli\u003eTier 2–3 regions = ~25% revenue\u003c\/li\u003e\n\u003cli\u003eMulti-brand carry increases switching risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Preference and Brand Loyalty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eKangji’s reputation for ergonomic, reliable laparoscopic tools drives surgeon preference, creating pull-through demand that weakens administrators’ price leverage; surveys in 2024 show 62% of Chinese laparoscopic surgeons cite brand reliability as top purchase driver.\u003c\/p\u003e\n\u003cp\u003eThat loyalty helps Kangji retain 18–25% premium pricing versus low-cost rivals, but competitor innovations and 12% annual price declines in some disposables keep loyalty under pressure.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSurgeon preference: 62% (2024 survey)\u003c\/li\u003e\n\u003cli\u003ePrice premium: 18–25% vs low-cost rivals\u003c\/li\u003e\n\u003cli\u003eDisposable price decline: ~12% YoY in segments\u003c\/li\u003e\n\u003cli\u003eNet effect: partial offset to admin bargaining power\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVBP slashes prices 56%: margins to ~18% as distributors, surgeon loyalty shape premiums\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers hold high power: national VBP cut consumable prices ~56% in 2024; public hospital tenders (RMB 200–800m\/SKU) and provincial aggregation force margin trade-offs. Kangji’s gross margin fell to ~18% in 2024 from 34% in 2019; 60% non-urban sales via distributors; surgeon loyalty (62% prefer reliability) allows 18–25% premium on key tools.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVBP avg price cut\u003c\/td\u003e\n\u003ctd\u003e56%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin (median)\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon-urban via distributors\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSurgeon preference\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eHangzhou Kangji Medical Equipment Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Hangzhou Kangji Medical Equipment Porter's Five Forces analysis you'll receive immediately after purchase—no surprises, no placeholders. It is the full, professionally formatted document covering competitive rivalry, supplier and buyer power, threats of new entrants and substitutes, with concise conclusions and strategic implications. Once you buy, you’ll get instant access to this same ready-to-use file.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747570332025,"sku":"hzkangji-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/hzkangji-five-forces-analysis.png?v=1772199949","url":"https:\/\/matrixbcg.com\/products\/hzkangji-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}